by Life Science Newswire | Feb 15, 2019 | Biotechnology, Corporate, Finance & Investor, Drug Discovery & Development, Pharma
Sygnature Discovery, the leading independent integrated drug discovery and pre-clinical services provider, have made two key appointments. Dr Allan Jordan and Ms Louisa Jordison have joined the organisation as they continue their strong growth trajectory in the drug...
by Life Science Newswire | Feb 6, 2019 | Corporate, Finance & Investor, Drug Discovery & Development, Pharma
Pathios Therapeutics and Sygnature Discovery sign a strategic and innovative partnership to develop first in class therapies in autoimmune disease and immuno-oncology Pathios Therapeutics (“Pathios”), an innovative biotech company focused on the development of first...
